RT Journal Article
SR Electronic
T1 The Acceleration Index as a Test-Controlled Reproduction Number: Application to COVID-19 in France*
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2020.12.01.20241570
DO 10.1101/2020.12.01.20241570
A1 Baunez, Christelle
A1 Degoulet, Mickael
A1 Luchini, Stéphane
A1 Pintus, Matteo L.
A1 Pintus, Patrick A.
A1 Teschl, Miriam
YR 2020
UL http://medrxiv.org/content/early/2020/12/02/2020.12.01.20241570.abstract
AB We show that the acceleration index, a novel indicator that measures acceleration and deceleration of viral spread (Baunez et al. 2020a,b), is essentially a test-controlled version of the reproduction number. As such it is a more accurate indicator to track the dynamics of an infectious disease outbreak in real time. We indicate a discrepancy between the acceleration index and the reproduction number, based on the infectivity and test rates and we provide a formal decomposition of this difference. When applied to French data for the ongoing COVID-19 pandemic, our decomposition shows that the reproduction number consistenly underestimates the resurgence of the pandemic since the summer of 2020, compared to the acceleration index which accounts for the time-varying volume of tests. From the comparison that we present here follows that the acceleration index is a sufficient statistic to track the pandemic’s propagation, as it captures in real time the sizeable time variation featured by viral circulation.JEL Classification Numbers I18; H12Competing Interest StatementThe authors have declared no competing interest.Funding StatementNo external funding.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:Not applicableAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesData used publicly available.